Puerarin improves insulin resistance and modulates adipokine expression in rats fed a high-fat diet

European Journal of Pharmacology

Volumn 649, Issue 1-3, 2010, Pages 398-402

  Zhang, Wei ^a   Liu, Chang Qin ^a,b   Wang, Peng Wen ^a,c   Sun, Su Yun ^a,c   Su, Wei Juan ^a,c   Zhang, Hui Jie ^a   Li, Xue Jun ^a   Yang, Shu Yu ^a  

^a Xiamen Diabetes Institute   (China)

^b THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

^c FUJIAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Adipokine; Adipose tissue; High fat diet; Insulin resistance; Puerarin

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; LEPTIN; MESSENGER RNA; PUERARIN; RESISTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HORMONE BLOOD LEVEL; INSULIN RESISTANCE; LIPID DIET; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; WHITE ADIPOSE TISSUE;

ADIPOKINES; ADIPONECTIN; ADIPOSE TISSUE, WHITE; ANIMALS; ANTI-OBESITY AGENTS; DIETARY FATS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE INTOLERANCE; INSULIN RESISTANCE; ISOFLAVONES; LEPTIN; MALE; METABOLIC SYNDROME X; OBESITY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RESISTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 78049259598     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.09.054     Document Type: Article

References (53)

1. Asensio C., Muzzin P., Rohner-Jeanrenaud F. Role of glucocorticoids in the physiopathology of excessive fat deposition and insulin resistance. Int. J. Obes. Relat. Metab. Disord. 2004, 28(Suppl 4):S45-S52.
2. Barnea M., Shamay A., Stark A.H., Madar Z. A high-fat diet has a tissue-specific effect on adiponectin and related enzyme expression. Obesity (Silver Spring) 2006, 14:2145-2153.
3. Berk E.S., Kovera A.J., Boozer C.N., Pi-Sunyer F.X., Johnson J.A., Albu J.B. Adiponectin levels during low- and high-fat eucaloric diets in lean and obese women. Obes. Res. 2005, 13:1566-1571.
4. Bryzgalova G., Lundholm L., Portwood N., Gustafsson J.A., Khan A., Efendic S., Dahlman-Wright K. Mechanisms of antidiabetogenic and body weight-lowering effects of estrogen in high-fat diet-fed mice. Am. J. Physiol. Endocrinol. Metab. 2008, 295:E904-E912.
5. Chang Y., Hsieh C.Y., Peng Z.A., Yen T.L., Hsiao G., Chou D.S., Chen C.M., Sheu J.R. Neuroprotective mechanisms of puerarin in middle cerebral artery occlusion-induced brain infarction in rats. J. Biomed. Sci. 2009, 16:9.
6. Deng Q.G., She H., Cheng J.H., French S.W., Koop D.R., Xiong S., Tsukamoto H. Steatohepatitis induced by intragastric overfeeding in mice. Hepatology 2005, 42:905-914.
7. Galili O., Versari D., Sattler K.J., Olson M.L., Mannheim D., McConnell J.P., Chade A.R., Lerman L.O., Lerman A. Early experimental obesity is associated with coronary endothelial dysfunction and oxidative stress. Am. J. Physiol. Heart Circ. Physiol. 2007, 292:H904-H911.
8. Gault V.A., McClean P.L., Cassidy R.S., Irwin N., Flatt P.R. Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria diets. Diabetologia 2007, 50:1752-1762.
9. Guerra M.C., Speroni E., Broccoli M., Cangini M., Pasini P., Minghett A., Crespi-Perellino N., Mirasoli M., Cantelli-Forti G., Paolini M. Comparison between chinese medical herb pueraria lobata crude extract and its main isoflavone puerarin antioxidant properties and effects on rat liver cyp-catalysed drug metabolism. Life Sci. 2000, 67:2997-3006.
10. Hara K., Yamauchi T., Kadowaki T. Adiponectin: An adipokine linking adipocytes and type 2 diabetes in humans. Curr. Diab. Rep. 2005, 5:136-140.
11. Ho S.C., Tai E.S., Eng P.H., Ramli A., Tan C.E., Fok A.C. A study in the relationships between leptin, insulin, and body fat in asian subjects. Int. J. Obes. Relat. Metab. Disord. 1999, 23:246-252.
12. Hu W., Zhang Q., Yang X., Wang Y., Sun L. Puerarin inhibits adhesion molecule expression in tnf-alpha-stimulated human endothelial cells via modulation of the nuclear factor kappab pathway. Pharmacology 2010, 85:27-35.
13. Hwang Y.P., Jeong H.G. Mechanism of phytoestrogen puerarin-mediated cytoprotection following oxidative injury: Estrogen receptor-dependent up-regulation of pi3k/akt and ho-1. Toxicol. Appl. Pharmacol. 2008, 233:371-381.
14. Iossa S., Lionetti L., Mollica M.P., Crescenzo R., Botta M., Barletta A., Liverini G. Effect of high-fat feeding on metabolic efficiency and mitochondrial oxidative capacity in adult rats. Br. J. Nutr. 2003, 90:953-960.
15. Kadowaki T., Yamauchi T., Kubota N., Hara K., Ueki K., Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest. 2006, 116:1784-1792.
16. Keller P., Moller K., Krabbe K.S., Pedersen B.K. Circulating adiponectin levels during human endotoxaemia. Clin. Exp. Immunol. 2003, 134:107-110.
17. Kim K.M., Jung D.H., Jang D.S., Kim Y.S., Kim J.M., Kim H.N., Surh Y.J., Kim J.S. Puerarin suppresses ages-induced inflammation in mouse mesangial cells: A possible pathway through the induction of heme oxygenase-1 expression. Toxicol. Appl. Pharmacol. 2010, 244:106-113.
18. Lee L., Alloosh M., Saxena R., Van Alstine W., Watkins B.A., Klaunig J.E., Sturek M., Chalasani N. Nutritional model of steatohepatitis and metabolic syndrome in the ossabaw miniature swine. Hepatology 2009, 50:56-67.
19. Lin R.C., Guthrie S., Xie C.Y., Mai K., Lee D.Y., Lumeng L., Li T.K. Isoflavonoid compounds extracted from pueraria lobata suppress alcohol preference in a pharmacogenetic rat model of alcoholism. Alcohol. Clin. Exp. Res. 1996, 20:659-663.
20. Liuzzi A., Savia G., Tagliaferri M., Lucantoni R., Berselli M.E., Petroni M.L., De Medici C., Viberti G.C. Serum leptin concentration in moderate and severe obesity: relationship with clinical, anthropometric and metabolic factors. Int. J. Obes. Relat. Metab. Disord. 1999, 23:1066-1073.
21. Malaivijitnond S., Tungmunnithum D., Gittarasanee S., Kawin K., Limjunyawong N. Puerarin exhibits weak estrogenic activity in female rats. Fitoterapia 2010, 81:569-576.
22. Meezan E., Meezan E.M., Jones K., Moore R., Barnes S., Prasain J.K. Contrasting effects of puerarin and daidzin on glucose homeostasis in mice. J. Agric. Food Chem. 2005, 53:8760-8767.
23. Muse E.D., Obici S., Bhanot S., Monia B.P., McKay R.A., Rajala M.W., Scherer P.E., Rossetti L. Role of resistin in diet-induced hepatic insulin resistance. J. Clin. Invest. 2004, 114:232-239.
24. Orgaard A., Jensen L. The effects of soy isoflavones on obesity. Exp. Biol. Med. (Maywood) 2008, 233:1066-1080.
25. Overstreet D.H., Lee Y.W., Rezvani A.H., Pei Y.H., Criswell H.E., Janowsky D.S. Suppression of alcohol intake after administration of the chinese herbal medicine, npi-028, and its derivatives. Alcohol. Clin. Exp. Res. 1996, 20:221-227.
26. Park Y.W., Zhu S., Palaniappan L., Heshka S., Carnethon M.R., Heymsfield S.B. The metabolic syndrome: Prevalence and associated risk factor findings in the us population from the third national health and nutrition examination survey, 1988-1994. Arch. Intern. Med. 2003, 163:427-436.
27. Park S.Y., Cho Y.R., Kim H.J., Higashimori T., Danton C., Lee M.K., Dey A., Rothermel B., Kim Y.B., Kalinowski A., Russell K.S., Kim J.K. Unraveling the temporal pattern of diet-induced insulin resistance in individual organs and cardiac dysfunction in c57bl/6 mice. Diabetes 2005, 54:3530-3540.
28. Peng Y., Rideout D., Rakita S., Sajan M., Farese R., You M., Murr M.M. Downregulation of adiponectin/adipor2 is associated with steatohepatitis in obese mice. J. Gastrointest. Surg. 2009, 13:2043-2049.
29. Quiros-Tejeira R.E., Rivera C.A., Ziba T.T., Mehta N., Smith C.W., Butte N.F. Risk for nonalcoholic fatty liver disease in hispanic youth with bmi>or =95th percentile. J. Pediatr. Gastroenterol. Nutr. 2007, 44:228-236.
30. Rezvani A.H., Overstreet D.H., Perfumi M., Massi M. Plant derivatives in the treatment of alcohol dependency. Pharmacol. Biochem. Behav. 2003, 75:593-606.
31. Ribot J., Rodriguez A.M., Rodriguez E., Palou A. Adiponectin and resistin response in the onset of obesity in male and female rats. Obesity (Silver Spring) 2008, 16:723-730.
32. Roberts C.K., Berger J.J., Barnard R.J. Long-term effects of diet on leptin, energy intake, and activity in a model of diet-induced obesity. J. Appl. Physiol. 2002, 93:887-893.
33. Shaw D.I., Hall W.L., Williams C.M. Metabolic syndrome: what is it and what are the implications?. Proc. Nutr. Soc. 2005, 64:349-357.
34. Shoelson S.E., Lee J., Goldfine A.B. Inflammation and insulin resistance. J. Clin. Invest. 2006, 116:1793-1801.
35. Steppan C.M., Lazar M.A. The current biology of resistin. J. Intern. Med. 2004, 255:439-447.
36. Steppan C.M., Bailey S.T., Bhat S., Brown E.J., Banerjee R.R., Wright C.M., Patel H.R., Ahima R.S., Lazar M.A. The hormone resistin links obesity to diabetes. Nature 2001, 409:307-312.
37. Sumiyoshi M., Sakanaka M., Kimura Y. Chronic intake of high-fat and high-sucrose diets differentially affects glucose intolerance in mice. J. Nutr. 2006, 136:582-587.
38. Teng Y., Cui H., Yang M., Song H., Zhang Q., Su Y., Zheng J. Protective effect of puerarin on diabetic retinopathy in rats. Mol. Biol. Rep. 2009, 36:1129-1133.
39. Townsend K.L., Lorenzi M.M., Widmaier E.P. High-fat diet-induced changes in body mass and hypothalamic gene expression in wild-type and leptin-deficient mice. Endocrine 2008, 33:176-188.
40. Tsuchiya K., Sakai H., Suzuki N., Iwashima F., Yoshimoto T., Shichiri M., Hirata Y. Chronic blockade of nitric oxide synthesis reduces adiposity and improves insulin resistance in high fat-induced obese mice. Endocrinology 2007, 148:4548-4556.
41. Velkoska E., Warner F.J., Cole T.J., Smith I., Morris M.J. Metabolic effects of low dose angiotensin converting enzyme inhibitor in dietary obesity in the rat. Nutr. Metab. Cardiovasc. Dis. 2010, 20:49-55.
42. Wagner J.D., Zhang L., Shadoan M.K., Kavanagh K., Chen H., Tresnasari K., Kaplan J.R., Adams M.R. Effects of soy protein and isoflavones on insulin resistance and adiponectin in male monkeys. Metabolism 2008, 57:S24-S31.
43. Wang Y., Yin L., Li Y., Liu P., Cui Q. Preventive effects of puerarin on alcohol-induced osteonecrosis. Clin. Orthop. Relat. Res. 2008, 466:1059-1067.
44. Woods S.C., Seeley R.J., Rushing P.A., D'Alessio D., Tso P. A controlled high-fat diet induces an obese syndrome in rats. J. Nutr. 2003, 133:1081-1087.
45. Wu L., Qiao H., Li Y., Li L. Protective roles of puerarin and danshensu on acute ischemic myocardial injury in rats. Phytomedicine 2007, 14:652-658.
46. Xiong F.L., Sun X.H., Gan L., Yang X.L., Xu H.B. Puerarin protects rat pancreatic islets from damage by hydrogen peroxide. Eur. J. Pharmacol. 2006, 529:1-7.
47. Xu M.E., Xiao S.Z., Sun Y.H., Zheng X.X., Ou-Yang Y., Guan C. The study of anti-metabolic syndrome effect of puerarin in vitro. Life Sci. 2005, 77:3183-3196.
48. Xu X., Zhang S., Zhang L., Yan W., Zheng X. The neuroprotection of puerarin against cerebral ischemia is associated with the prevention of apoptosis in rats. Planta Med. 2005, 71:585-591.
49. Yan L.P., Chan S.W., Chan A.S., Chen S.L., Ma X.J., Xu H.X. Puerarin decreases serum total cholesterol and enhances thoracic aorta endothelial nitric oxide synthase expression in diet-induced hypercholesterolemic rats. Life Sci. 2006, 79:324-330.
50. Yang B., Chen L., Qian Y., Triantafillou J.A., McNulty J.A., Carrick K., Clifton L.G., Han B., Geske R., Strum J., Brown K.K., Stimpson S.A., Pahel G. Changes of skeletal muscle adiponectin content in diet-induced insulin resistant rats. Biochem. Biophys. Res. Commun. 2006, 341:209-217.
51. Zhang S., Ji G., Liu J. Reversal of chemical-induced liver fibrosis in wistar rats by puerarin. J. Nutr. Biochem. 2006, 17:485-491.
52. Zhang H.M., Chen S.W., Zhang L.S., Feng X.F. The effects of soy isoflavone on insulin sensitivity and adipocytokines in insulin resistant rats administered with high-fat diet. Nat. Prod. Res. 2008, 22:1637-1649.
53. Zhu L.H., Wang L., Wang D., Jiang H., Tang Q.Z., Yan L., Bian Z.Y., Wang X.A., Li H. Puerarin attenuates high-glucose-and diabetes-induced vascular smooth muscle cell proliferation by blocking pkcbeta2/rac1-dependent signaling. Free Radic. Biol. Med. 2010, 48:471-482.